Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0988
Source ID: NCT03619850
Associated Drug: Ferumoxytol
Title: A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Acronym:
Status: RECRUITING
Study Results: NO
Results:
Conditions: Chronic Kidney Disease; Iron Deficiency Anemia
Interventions: DRUG: Ferumoxytol|DRUG: Iron sucrose
Outcome Measures: Primary: Hemoglobin change of at least 0.5 g/dL from Baseline to Week 5, Proportion of patients achieving a hemoglobin change of at least 0.5 g/dL during the period from Baseline to Week 5, 35 days | Secondary: Incidence of Treatment Emergent Adverse Events, Incidence of Treatment Emergent Adverse Events, 49 days|Incidence of adverse events of special interest (AESI), Incidence of adverse events of special interest (AESI) (hypotension and hypersensitivity), 49 days | Other: Area Under the Curve (AUC), Pharmacokinetic parameter: Area Under the Curve (AUC), 35 days|Clearance, Pharmacokinetic parameter: clearance, 35 days|Distribution and elimination half-lives, Pharmacokinetic parameter: distribution and elimination half-lives, 35 days
Sponsor/Collaborators: Sponsor: AMAG Pharmaceuticals, Inc.
Gender: ALL
Age: CHILD
Phases: PHASE3
Enrollment: 129
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2018-08-13
Completion Date: 2024-08-31
Results First Posted:
Last Update Posted: 2024-08-12
Locations: Memorial Healthcare System, Hollywood, Florida, 33021, United States|Wayne State University, Detroit, Michigan, 48201, United States|Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|Montefiore Medical Center (MMC) - The Children's Hospital at Montefiore (CHAM), Bronx, New York, 10467, United States|The Feinstein Institute Medical Research Organization of Northwell Health, Inc., Lake Success, New York, 11042, United States|Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York, New York, 10029, United States|Akron Nephrology Associates, Inc., Akron, Ohio, 44302, United States|West Virginia University, Morgantown, West Virginia, 26506, United States|Semmelweis Egyetem - Altalanos Orvostudomanyi Kar (SE AOK) - I. sz. Gyermekgyogyaszati Klinika, Budapest, Hungary|University Of Szeged, Szeged, Hungary|Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas, Lithuania|Klaipeda Children's Hospital, Klaipėda, Lithuania|Vsl Vilniaus Universiteto Vaiku Ligonine (VUVL) (Vilnius University Children's Hospital), Vilnius, Lithuania|Instituto Mexicano De Trasplantes S.C, Cuernavaca, Mexico|JM Research, SC, Cuernavaca, Mexico|Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico|Instituto Nacional de Pediatria (INP) (National Institute of Pediatrics), Mexico City, Mexico|Uniwersytecki Szpital Kliniczny Im. Zamenhofa w Bialystoku, Białystok, Poland|Specjalistyczne Gabinety Sp. z o.o, Kraków, Poland|University Children Hospital, Kraków, Poland|Polish Mother's Memorial Hospital Research Institute, Łódź, Poland
URL: https://clinicaltrials.gov/show/NCT03619850